Literature DB >> 21199121

Whole-lung lavage in infants and children with pulmonary alveolar proteinosis.

Karl Reiter1, Carola Schoen, Matthias Griese, Thomas Nicolai.   

Abstract

BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare alveolar filling syndrome where the mainstay of treatment is therapeutic whole-lung lavage (WLL). WLL techniques used in adults have to be modified for children because of their small-diameter airways. AIM: To describe a technique for WLL adapted for small children.
METHODS: We describe a WLL technique that combines safe single-lung ventilation with the use of an age-appropriate endotracheal tube and selective occlusion of the other main bronchus with a balloon catheter through which the lavage is performed. Effectiveness measured by change in oxygen requirements and adverse effects was noted.
RESULTS: We performed 64 WLL procedures in four children (age 13 months to 7 years; body weight 4.7-14 kg). Two children had idiopathic and two had secondary PAP. At referral, all children had dyspnoea at rest and required continuous oxygen supplementation. Two patients showed significantly decreased oxygen demands and radiological improvement after WLL. Two patients showed no significant response. The only adverse effect observed was transient hypoxemia. Complications comprised fluid leak at the balloon (4), balloon rupture (1), and pneumothorax (1).
CONCLUSIONS: This technique for WLL combining single-lung ventilation with an endotracheal tube and lung exclusion for lavage with a balloon catheter can be safely and effectively performed in small children with PAP.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21199121     DOI: 10.1111/j.1460-9592.2010.03442.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

Review 1.  Pulmonary alveolarproteinosis in children.

Authors:  Andrew Bush; Rishi Pabary
Journal:  Breathe (Sheff)       Date:  2020-06

2.  An Alternative Lung Isolation Technique in Paediatric Pulmonary Alveolar Proteinosis.

Authors:  Tümay Umuroğlu; Merve Altıntaş; Tural Abdullayev; Gürsu Kıyan; Hilmi Ö Ayanoğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-10-01

3.  Long-term follow-up and treatment of congenital alveolar proteinosis.

Authors:  Matthias Griese; Jan Ripper; Anke Sibbersen; Pia Lohse; Peter Lohse; Frank Brasch; Andrea Schams; Asli Pamir; Bianca Schaub; Oliver J Muensterer; Carola Schön; Judith Glöckner-Pagel; Thomas Nicolai; Karl Reiter; Andreas Hector
Journal:  BMC Pediatr       Date:  2011-08-17       Impact factor: 2.125

4.  Whole-lung lavage complicated with pneumothorax: a case report.

Authors:  Hyun-Joo Ahn; Mikyung Yang; Jie Ae Kim; Burnyoung Heo; Jin-Kyoung Kim; So Yoon Park
Journal:  Korean J Anesthesiol       Date:  2017-05-19

5.  GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.

Authors:  Matthias Griese; Ralf Zarbock; Ulrich Costabel; Jenna Hildebrandt; Dirk Theegarten; Michael Albert; Antonia Thiel; Andrea Schams; Joanna Lange; Katazyrna Krenke; Traudl Wesselak; Carola Schön; Matthias Kappler; Helmut Blum; Stefan Krebs; Andreas Jung; Carolin Kröner; Christoph Klein; Ilaria Campo; Maurizio Luisetti; Francesco Bonella
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

6.  Pulmonary alveolar proteinosis in a cat.

Authors:  Viktor Szatmári; Erik Teske; Peter G J Nikkels; Matthias Griese; Pim A de Jong; Guy Grinwis; Dirk Theegarten; Stefanie Veraa; Frank G van Steenbeek; Marjolein Drent; Francesco Bonella
Journal:  BMC Vet Res       Date:  2015-12-09       Impact factor: 2.741

Review 7.  Respiratory strategies and airway management in patients with pulmonary alveolar proteinosis: a review.

Authors:  Tomas Vymazal; Martina Krecmerova
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.